EXPLEOSOL — Expleo Solutions Income Statement
0.000.00%
Last trade - 00:00
- IN₹13.49bn
- IN₹12.14bn
- IN₹6.25bn
- 62
- 32
- 46
- 42
2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,828 | 2,694 | 3,009 | 7,425 | 6,247 |
Cost of Revenue | |||||
Gross Profit | 2,778 | 2,644 | 2,930 | 7,079 | 6,238 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,351 | 2,228 | 2,369 | 6,372 | 5,131 |
Operating Profit | 476 | 466 | 640 | 1,053 | 1,116 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 536 | 541 | 684 | 1,101 | 1,254 |
Provision for Income Taxes | |||||
Net Income After Taxes | 362 | 399 | 504 | 677 | 928 |
Net Income Before Extraordinary Items | |||||
Net Income | 362 | 399 | 504 | 677 | 928 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 362 | 399 | 504 | 677 | 928 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 33.8 | 38.5 | 49.2 | 66 | 72.2 |
Dividends per Share |